Globus Medical Inc Class A (GMED)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$58.00

Buy

$58.24

arrow-down$-0.76 (-1.29%)

Prices updated at 14 May 2025, 00:10 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.
S&P 500
arrow-up0.72%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. David C. Paul
CEO
Mr. Daniel T. Scavilla
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
5,300
Head office
2560 General Armistead Avenue
Audubon
United States
19403
mobile
+1 610 930-1800
letter
investors@globusmedical.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. James R. Tobin
Independent Director
0.09m
Dr. John A. DeFord, PhD
Independent Director
0.08m
Mr. Robert Andrew Douglas
Independent Director
0.08m
Mr. Stephen T. Zarrilli
Independent Director
0.08m
Ms. Ann D. Rhoads
Independent Director
0.11m
Mr. Daniel T. Lemaitre
Independent Director
0.09m
Ms. Leslie V. Norwalk, Esq.
Independent Director
0.08m
Mr. David D. Davidar
Independent Director
0.09m
Mr. David C. Paul
Executive Chairman of the Board
0.46m
Mr. Daniel J. Wolterman
Independent Director
0.08m
Mr. Daniel T. Scavilla
Director, President and Chief Executive Officer
0.48m
Mr. Keith W. Pfeil
Chief Accounting Officer, Chief Operating Officer and Chief Financial Officer
0.46m
Ms. Kelly G. Huller
Executive Vice President, General Counsel and Corporate Secretary
0.36m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc10,863,834
BlackRock Inc10,636,843
HHG PLC6,614,812
BlackRock Fund Advisors6,416,157
Janus Capital Management LLC4,419,036

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
21 Nov 2024-
21 Nov 2024-
22 Nov 2024-
22 Nov 2024-
21 Nov 2024-
22 Nov 2024-
22 Nov 2024-
22 Nov 2024-
21 Nov 2024-
21 Nov 2024-
21 Nov 2024-
21 Nov 2024-
21 Nov 2024-
21 Nov 2024-
21 Nov 2024-
15 Nov 2024-
15 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.